Kindly MD Inc
NASDAQ:KDLY
Kindly MD Inc
Research & Development
Kindly MD Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kindly MD Inc
NASDAQ:KDLY
|
Research & Development
-$377.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Research & Development
-$359.5m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Kindly MD Inc
Glance View
Kindly MD, Inc. provided healthcare services. The company is headquartered in Salt Lake City, Utah and currently employs 23 full-time employees. The company went IPO on 2024-05-31. The firm offers direct health care to patients, integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a fee-for-service basis. The firm offers evaluation and management, including, but not limited to, chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. The firm also collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The firm captures all relevant data points to assist and appropriately treat each individual patient.
See Also
What is Kindly MD Inc's Research & Development?
Research & Development
-377.7k
USD
Based on the financial report for Dec 31, 2024, Kindly MD Inc's Research & Development amounts to -377.7k USD.